Research Library

David R. Brockman and Edward M. Emmett discuss three high-profile bills introduced by Texas lawmakers in 2023 and their connection to a broader movement that seeks to privilege Christianity in public schools.

Over half of all Americans live in a state where cannabis is legalized. And yet, the federal government has not reclassified marijuana since 1970. According to the Controlled Substances Act, it is considered a “Schedule 1” substance — the same classification as heroin and crack cocaine with no accepted medical use.

Despite its massive geological endowment and receiving what could be considered the largest windfall in its economic history, Venezuela entered 2020 in the middle of an unprecedented economic crisis. The Covid-19 pandemic and turbulence in oil markets represent the latest in a string of problems that expose the country’s vulnerability.

Former Secretary of State James A. Baker, III, testified on May 12, 2016, before the Senate Committee on Foreign Relations on America's role in the world.

Constantino Urcuyo, nonresident fellow for the Latin America Initiative, testified at a House Foreign Affairs subcommittee hearing on Russia's engagement in Latin America.

William Martin, director of the Drug Policy Program, and Katharine A. Neill, Alfred C. Glassell, III Postdoctoral Fellow in Drug Policy, testify about the likelihood of marijuana being used as a gateway to harder drugs and the effects of decriminalization on teen use rates before the Texas House Criminal Jurisprudence Committee.